id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-E-0249-0007,FDA,FDA-2005-E-0249,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-10-18T04:00:00Z,2006,10,,,2025-12-03T20:34:21Z,,0,0,09000064804441c5
FDA-2005-E-0249-0006,FDA,FDA-2005-E-0249,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2006-06-20T04:00:00Z,2006,6,,,2025-12-03T20:30:02Z,,0,0,09000064804441c4
FDA-2005-E-0249-0005,FDA,FDA-2005-E-0249,Determination of Regulatory Review Period for Purposes of Patent Extension; OVIDREL,Notice,General Notice,2006-03-17T05:00:00Z,2006,3,2006-03-15T05:00:00Z,,2025-12-03T20:18:26Z,E6-3640,0,0,09000064804441c0
FDA-2005-E-0249-0004,FDA,FDA-2005-E-0249,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-02-27T05:00:00Z,2006,2,,,2025-12-03T20:11:11Z,,0,0,09000064804441be